MedTrace Logo

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

NCT06752395 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-01-03

No results posted yet for this study

Summary

This multicenter clinical trial evaluates the diagnostic yields of cryobiopsy and forceps biopsy for peripheral lung nodules. In the cryobiopsy group, cryobiopsy is the primary method, supplemented by forceps biopsy. Conversely, in the forceps biopsy group, forceps biopsy is the primary method, supplemented by cryobiopsy. The study also explores the complementary relationship between the two methods and examines differences in diagnostic rates based on the order in which the procedures are performed.

Conditions

  • Lung Cancer (NSCLC)

Interventions

DIAGNOSTIC_TEST

Transbronchial lung biopsy with radial probe endobronchial ultrasound (Cryobiopsy centered)

When the lung nodule is visualized by bronchoscope using RP-EBUS, cryobiopsy is performed, followed by forceps biopsy.

DIAGNOSTIC_TEST

Transbronchial lung biopsy with radial probe endobronchial ultrasound (Forceps biopsy centered)

When the lung nodule is visualized by bronchoscope using RP-EBUS, forceps biopsy is performed, followed by cryobiopsy.

Sponsors & Collaborators

  • Erbe-med

    collaborator UNKNOWN

  • Pusan National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-11-01
Completion
2026-11-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06752395 on ClinicalTrials.gov